This review is a summary of an individual study; Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials.
Independent commentary is provided by Dr Jakob Begun, who is the IBD clinical lead at the Mater Hospital in Brisbane. This retrospective analysis includes over 7000 patients.
Please login below to download this issue (PDF)